I agree that this site is using cookies. You can find further informations here.
X
Mastorino L
143  results:
Search for persons X
?
1

'Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fai..:

Mastorino, L. ; Ortoncelli, M. ; Dapavo, P...
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  2 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
2

Drug survival, effectiveness and safety of ixekizumab for m..:

Mastorino, L. ; Dapavo, P. ; Burzi, L....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  3 - p. 568-575 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Efficacy of tralokinumab after failure with upadacitinib an..:

Mastorino, L. ; Gelato, F. ; Quaglino, P...
Journal of Dermatological Treatment.  34 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
4

Impact of comorbidities in elderly and frail patients and r..:

Rosset, F. ; Mastorino, L. ; Dapavo, P...
Experimental Dermatology.  32 (2023)  7 - p. 1162-1164 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fail..:

Mastorino, L. ; Susca, S. ; Cariti, C....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  9 - p. 1848-1853 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Primary cutaneous lymphoma patients seen at a referral derm..:

Macagno, N. ; Mastorino, L. ; Rubatto, M....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  12 - p. 2388-2392 , 2022
Link: https://doi.org/10.1111/..
 
?
7

Impact of comorbidities in the response of atopic patients ..:

Mastorino, L. ; Cantafio Duò, V.L. ; Vecco, C....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  12 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
8

Real‐life comparison between secukinumab and ixekizumab in ..:

Avallone, G. ; Cariti, C. ; Dapavo, P....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  7 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
9

Risankizumab shows faster response in bio naïve than in bio..:

Mastorino, L. ; Castelli, F. ; Stroppiana, E....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  10 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
10

Comparison of Secukinumab and Ixekizumab in psoriasis: a re..:

Cariti, C. ; Dapavo, P. ; Mastorino, L....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
11

Drug survival, effectiveness, and safety of brodalumab for ..:

Mastorino, Luca ; Dapavo, Paolo ; Burzi, Lorenza...
International Journal of Dermatology.  63 (2024)  7 - p. 922-928 , 2024
Link: https://doi.org/10.1111/..
 
?
12

Association between maternal dupilumab exposure and pregnan..:

Avallone, Gianluca ; Cavallo, Francesco ; Tancredi, Annalisa...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
13

Alcohol abuse and discretionary habits in psoriatic patient..:

Mastorino, Luca ; Daniele, Rebecca ; Dapavo, Paolo...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  , 2024
Link: https://doi.org/10.1111/..
 
?
14

Drug Survival, Safety, and Effectiveness of Secukinumab for..:

Mastorino, Luca ; Dapavo, Paolo ; Cariti, Caterina...
Journal of Personalized Medicine.  14 (2024)  7 - p. 718 , 2024
Link: https://doi.org/10.3390/..
 
?
15

Multi‐failure psoriasis patients: characterization of the p..:

Viola, Riccardo ; Mastorino, Luca ; Megna, Matteo...
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
1-15